Drug Profile
Research programme: Haemophilus influenzae type b vaccine - BioNet-Asia
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator BioNet-Asia
- Class Haemophilus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Haemophilus infections
Most Recent Events
- 01 Dec 2017 Discontinued for Haemophilus infections in Thailand (Parenteral)
- 16 Jul 2016 No recent reports of development identified for research development in Haemophilus-infections in Thailand (Parenteral, Injection)
- 01 Oct 2012 Early research in Haemophilus infections in Thailand (Parenteral)